Balansag, Christyl Mae S.
HRN: 07-64-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2022
CEFTRIAXONE 1G (VIAL)
08/08/2022
08/14/2022
IVTT
2g
Q24hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes